COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,822 Articles (22,968 medRxiv, 8,854 bioRxiv)

Most recent first Previous |  Page 2021: Articles 20201-20210  | Next

History of premorbid depression is a risk factor for COVID-related mortality: Analysis of a retrospective cohort of 1,387 COVID+ patients
Clouston, S., Luft, B. J., Sun, E.
10.1101/2020.12.17.20248362 — Posted: 2020-12-19
Coinfection with Respiratory Pathogens in COVID-19 in Korea
Roh, K. H., Kim, Y. K., Kim, S.-W., Kang, E.-R., Yang, Y.-J., Jung, S.-K., Lee, S.-H., Sung, N.
10.1101/2020.12.18.20248449 — Posted: 2020-12-19
Excess deaths among Latino people in California during the COVID-19 pandemic
Riley, A. R., Chen, Y.-H., Matthay, E. C., Glymour, M. M., Torres, J. M., Fernandez, A., Bibbins-Domingo, K.
10.1101/2020.12.18.20248434 — Posted: 2020-12-19
On the timing of interventions to preserve hospital capacity: lessons to be learned from the Belgian SARS-CoV-2 pandemic
Hens, N., Faes, C., Gilbert, M.
10.1101/2020.12.18.20248450 — Posted: 2020-12-19
Current evidence for COVID-19 therapies: a systematic literature review
Welte, T., Ambrose, L. J., Sibbring, G. C., Sheikh, S., Müllerova, H., Sabir, I.
10.1101/2020.12.18.20248452 — Posted: 2020-12-19
Detection of SARS-CoV2 antigen in human saliva may be a reliable tool for large scale screening
Kannian, P., Lavanya, C., Ravichandran, K., Jayaraman, B. G., Mahanathi, P., Ashwini, V., Kumarasamy, N., Rajan, G., Ranganathan, K., Challacombe, S. J., Webster-Cyriaque, J., Johnson, N. W.
10.1101/2020.12.17.20248437 — Posted: 2020-12-19
CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical setting
Khan, W. A., Barney, R. E., Tsongalis, G. J.
10.1101/2020.12.17.20228593 — Posted: 2020-12-19
SARS-CoV-2 infection, risk perception, behaviour, and preventive measures at schools in Berlin, Germany, during the early post-lockdown phase: A cross-sectional study
Hommes, F., van Loon, W., Thielecke, M., Abramovich, I., Lieber, S., Hammerich, R., Gehrke-Beck, S., Linzbach, E., Schuster, A., von dem Busche, K., Theuring, S., Gertler, M., Equihua Martinez, G., Richter, J., Bergmann, C., Bölke, A., Böhringer, F., Mall, M. A., Rosen, A., Krannich, A., Keller, J., Bethke, N., Kurzmann, M., Kurth, T., Kirchberger, V., Seybold, J., Mockenhaupt, F. P.
10.1101/2020.12.18.20248398 — Posted: 2020-12-19
Blood group A Secretors are associated with a higher risk of COVID-19 cardiovascular disease complications
Mankelow, T. J., Singleton, B. K., Moura, P. L., Stevens-Hernandez, C. J., Cogan, N. M., Gyorffy, G., Kupzig, S., Nicholas, L., Asby, C., Pooley, J., Ruffino, G., Hossseini, F., Moghaddas, F., Attwood, M., Noel, A., Cooper, A., Arnold, D., Hamilton, F., Hyams, C., Finn, A., Toye, A. M., Anstee, D. J.
10.1101/2020.12.19.20248172 — Posted: 2020-12-19
Assessing Global Covid-19 Cases Data through Compositional Data Analysis(CoDa)
Braga, L., Feingenbaun, D.
10.1101/2020.12.17.20248424 — Posted: 2020-12-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).